SRPT Sarepta Corp: Year-over-year net earnings per share growth for the last 12 months

Brandmark of Sarepta (SRPT)

Sarepta Therapeutics, Inc. (SRPT) faces risks associated with R&D expenditures and a reliance on insurance reimbursements, as evidenced by the quarterly EPS growth history. Stability is provided by the protection of intellectual property against cyber threats and exclusive patents for the treatment of Duchenne muscular dystrophy. Within this trend, the 85.60 metric serves as the target level, signaling the current fundamental business efficiency and the operational resilience of the company.

SRPT: sarepta.com Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 11/18/2026

Analytical breakdowns for Sarepta Therapeutics, Inc.

Summary company analytics:Sarepta Therapeutics - SRPT
Flagship merchandise of Sarepta Therapeutics, Inc.

The scaling of the gene therapy portfolio at Sarepta Therapeutics, Inc. (SRPT) is directly reflected in the dynamics of quarterly earnings per share growth. This metric captures daily changes in net income growth rates, transforming business expansion into actual share value. By analyzing the volatility of the quarterly EPS, investors can determine the effectiveness of drug commercialization. This calculation allows for the separation of temporary peaks from the sustainable trend, confirming the long-term financial viability of the company's model.

Competitor analysis

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Twist Bioscience (TWST) - Year-over-year net earnings per share growth for the last 12 months|TXG: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Quarterly EPS earnings growth|BLFS (BioLife Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Wave Life Sciences Ltd. (WVE)|Year-over-year earnings per share growth rate for the last twelve months MAZE|sionnatx.com - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRME|TSHA - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months RGNX|Year-over-year net earnings per share growth for the last 12 months SLDB|Quarterly EPS earnings growth Ocugen Inc|Year-over-year earnings per share growth for the last twelve months PacBio Corp (PACB)|Year-over-year net earnings per share change for the last twelve months Benitec Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)